KENDALL DYKE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ABERDEEN, SD NPI 1558029173
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SD Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$970.55
- Category: General Payments
- Program years: PY2022–2024
- Record count: 38
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $947.00 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $830.78 | 34 |
| Education | $116.22 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $150.26 | 3 |
| Ipsen Biopharmaceuticals, Inc | $123.77 | 3 |
| Merck Sharp & Dohme Corporation | $121.01 | 4 |
| EISAI INC. | $82.18 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.92 | 2 |
| Lilly USA, LLC | $41.91 | 2 |
| TerSera Therapeutics LLC | $39.09 | 2 |
| Incyte Corporation | $35.18 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $33.52 | 2 |
| Karyopharm Therapeutics Inc. | $32.97 | 1 |
| Stemline Therapeutics Inc. | $31.16 | 2 |
| ABBVIE INC. | $28.21 | 1 |
| TAIHO ONCOLOGY, INC. | $23.77 | 1 |
| Daiichi Sankyo Inc. | $23.23 | 1 |
| GlaxoSmithKline, LLC. | $22.92 | 1 |
| PharmaEssentia USA Corporation | $20.57 | 1 |
| SpringWorks Therapeutics, Inc. | $20.45 | 1 |
| Genentech USA, Inc. | $19.33 | 1 |
| Gilead Sciences, Inc. | $17.16 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.09 | 1 |
| Acerta Pharma LLC | $13.30 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.